|
SE506164C2
(sv)
*
|
1995-10-09 |
1997-11-17 |
Medscand Medical Ab |
Instrumentarium för behandling av urininkontinens hos kvinnor
|
|
US5972379A
(en)
*
|
1995-02-14 |
1999-10-26 |
Sequus Pharmaceuticals, Inc. |
Liposome composition and method for administering a quinolone
|
|
ATE252372T1
(de)
*
|
1996-08-23 |
2003-11-15 |
Sequus Pharm Inc |
Liposome enthaltend cisplatin
|
|
FR2759293B1
(fr)
*
|
1997-02-11 |
1999-04-30 |
Ethypharm Lab Prod Ethiques |
Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
|
|
DE19724796A1
(de)
*
|
1997-06-06 |
1998-12-10 |
Max Delbrueck Centrum |
Mittel zur Antitumortherapie
|
|
CA2346879A1
(en)
|
1998-09-16 |
2000-04-27 |
Alza Corporation |
Liposome-entrapped topoisomerase inhibitors
|
|
US20050084524A1
(en)
*
|
1998-09-30 |
2005-04-21 |
Alza Corporation |
Method for potentiating activity of a chemotherapeutic drug
|
|
US7121997B2
(en)
*
|
1999-06-09 |
2006-10-17 |
Ethicon, Inc. |
Surgical instrument and method for treating female urinary incontinence
|
|
DK1581162T3
(da)
*
|
1999-06-09 |
2011-08-01 |
Ethicon Inc |
Indretning til justering af polymerimplantater ved bløde overflader
|
|
US6932759B2
(en)
|
1999-06-09 |
2005-08-23 |
Gene W. Kammerer |
Surgical instrument and method for treating female urinary incontinence
|
|
US7226407B2
(en)
|
1999-06-09 |
2007-06-05 |
Ethicon, Inc. |
Surgical instrument and method for treating female urinary incontinence
|
|
US6511676B1
(en)
*
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
WO2001041738A2
(en)
*
|
1999-12-10 |
2001-06-14 |
Celator Technologies Inc. |
Lipid carrier compositions with protected surface reactive functions
|
|
DE60110057T2
(de)
*
|
2000-01-28 |
2005-09-08 |
Alza Corp., Mountain View |
Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung
|
|
US7131943B2
(en)
*
|
2000-03-09 |
2006-11-07 |
Ethicon, Inc. |
Surgical instrument and method for treating organ prolapse conditions
|
|
DE10019604C2
(de)
*
|
2000-04-20 |
2002-06-27 |
Ethicon Gmbh |
Implantat
|
|
JP2001336528A
(ja)
*
|
2000-05-25 |
2001-12-07 |
Ntn Corp |
磁気浮上装置
|
|
US7025063B2
(en)
*
|
2000-09-07 |
2006-04-11 |
Ams Research Corporation |
Coated sling material
|
|
EP1324758B1
(de)
*
|
2000-10-03 |
2005-01-12 |
Debiopharm S.A. |
Plga/pla-typ mikrokugeln enthaltend eine wasserlösliche verbindung und herstellungsverfahren dafür
|
|
JP4623931B2
(ja)
*
|
2000-12-07 |
2011-02-02 |
エンセラデュス、ファーマシューティカルズ、ベスローテン、フェンノートシャップ |
炎症性疾患の治療用組成物
|
|
US6612977B2
(en)
|
2001-01-23 |
2003-09-02 |
American Medical Systems Inc. |
Sling delivery system and method of use
|
|
US6641525B2
(en)
*
|
2001-01-23 |
2003-11-04 |
Ams Research Corporation |
Sling assembly with secure and convenient attachment
|
|
US6802807B2
(en)
|
2001-01-23 |
2004-10-12 |
American Medical Systems, Inc. |
Surgical instrument and method
|
|
DE10107165A1
(de)
*
|
2001-02-15 |
2002-08-29 |
Max Planck Gesellschaft |
Thermolabiles Liposom mit geregelter Freigabetemperatur
|
|
WO2002078672A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Alza Corporation |
Liposomal tumor necrosis factor compositions and methods
|
|
JP2005502653A
(ja)
*
|
2001-08-20 |
2005-01-27 |
トランセーヴ・インコーポレーテッド |
肺ガンの治療方法
|
|
CA2457148A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Transave, Inc. |
Treatment of cancers by inhalation of stable platinum-containing formulations
|
|
CN101062053A
(zh)
*
|
2001-09-24 |
2007-10-31 |
托斯克公司 |
减低毒性的顺铂制剂及其使用方法
|
|
US7087065B2
(en)
*
|
2001-10-04 |
2006-08-08 |
Ethicon, Inc. |
Mesh for pelvic floor repair
|
|
US20050118250A1
(en)
*
|
2001-11-13 |
2005-06-02 |
Paul Tardi |
Lipid carrier compositions with enhanced blood stability
|
|
US6476068B1
(en)
|
2001-12-06 |
2002-11-05 |
Pharmacia Italia, S.P.A. |
Platinum derivative pharmaceutical formulations
|
|
AU2003215843C1
(en)
|
2002-03-01 |
2009-02-19 |
Ethicon, Inc. |
Method and apparatus for treating pelvic organ prolapses in female patients
|
|
AU2003230600B2
(en)
*
|
2002-03-05 |
2009-06-04 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
|
US20030215493A1
(en)
*
|
2002-04-30 |
2003-11-20 |
Patel Pravin M. |
Composition and method for dermatological treatment
|
|
US20110142922A1
(en)
*
|
2002-04-30 |
2011-06-16 |
Ferndale Ip, Inc. |
Stabilized composition and method for dermatological treatment
|
|
US20090060992A1
(en)
*
|
2002-05-08 |
2009-03-05 |
University Of Central Florida Research Foundation, Inc., |
Preparation of magneto-vesicles with DOPE/DDAB layers
|
|
JP3415131B1
(ja)
|
2002-06-03 |
2003-06-09 |
メビオファーム株式会社 |
リポソーム製剤
|
|
US20040022842A1
(en)
*
|
2002-06-03 |
2004-02-05 |
Mebiopharm Co., Ltd. |
Liposome preparations containing oxaliplatin
|
|
US20050152962A1
(en)
*
|
2002-06-12 |
2005-07-14 |
Metselaar Josbert M. |
Composition for treatment of inflammatory disorders
|
|
WO2004054499A2
(en)
*
|
2002-08-02 |
2004-07-01 |
Transave, Inc. |
Platinum aggregates and process for producing the same
|
|
US9186322B2
(en)
*
|
2002-08-02 |
2015-11-17 |
Insmed Incorporated |
Platinum aggregates and process for producing the same
|
|
EP1393720A1
(de)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesikel enthaltend Corticosteroide zur Behandlung von Krebs
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
AU2003304204B2
(en)
*
|
2002-10-29 |
2009-12-24 |
Insmed Incorporated |
Sustained release of antiinfectives
|
|
AU2003298738A1
(en)
*
|
2002-11-26 |
2004-06-18 |
Su-Ming Chiang |
Liposomal formulations
|
|
CA2510780A1
(en)
*
|
2002-12-19 |
2004-07-08 |
Alza Corporation |
Method of treating angiogenic tissue growth
|
|
DE60330745D1
(de)
*
|
2002-12-31 |
2010-02-11 |
Bharat Serums & Vaccines Ltd |
Nicht-pegylierte lang-zirkulierende Liposome
|
|
WO2004078121A2
(en)
*
|
2003-02-28 |
2004-09-16 |
Alza Coporation |
Liposome composition for reduction of liposome-induced complement activation
|
|
US7968115B2
(en)
*
|
2004-03-05 |
2011-06-28 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of cancer
|
|
WO2004087097A2
(en)
*
|
2003-03-31 |
2004-10-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
|
|
AU2004240640A1
(en)
*
|
2003-05-19 |
2004-12-02 |
Baxter International Inc. |
Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers
|
|
EP1663153A4
(de)
*
|
2003-05-20 |
2011-01-05 |
Aronex Pharmaceuticals Inc |
Kombinationschemotherapie mit einem liposomalen platinkomplex
|
|
WO2005018607A1
(ja)
*
|
2003-08-20 |
2005-03-03 |
Ajinomoto Co., Inc. |
溶解性を改善した医薬品製剤
|
|
CN100471493C
(zh)
*
|
2003-12-17 |
2009-03-25 |
梅比欧法姆股份有限公司 |
含有奥沙利铂的脂质体制剂
|
|
US20080103213A1
(en)
*
|
2004-03-05 |
2008-05-01 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of neurofibromatosis
|
|
US8784881B2
(en)
*
|
2004-03-05 |
2014-07-22 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of diseases
|
|
AU2005223654A1
(en)
*
|
2004-03-18 |
2005-09-29 |
Transave, Inc. |
Administration of cisplatin by inhalation
|
|
US20070065522A1
(en)
*
|
2004-03-18 |
2007-03-22 |
Transave, Inc. |
Administration of high potency platinum compound formulations by inhalation
|
|
US8047982B2
(en)
*
|
2004-05-07 |
2011-11-01 |
Ethicon, Inc. |
Mesh tape with wing-like extensions for treating female urinary incontinence
|
|
AU2005245018A1
(en)
*
|
2004-05-21 |
2005-12-01 |
Transave, Inc. |
Treatment of lung diseases and pre-lung disease conditions
|
|
US7297102B2
(en)
*
|
2004-07-28 |
2007-11-20 |
Ethicon, Inc. |
Minimally invasive medical implant and insertion device and method for using the same
|
|
JP2006056807A
(ja)
*
|
2004-08-18 |
2006-03-02 |
Konica Minolta Medical & Graphic Inc |
光線力学療法製剤
|
|
JP4715133B2
(ja)
*
|
2004-08-26 |
2011-07-06 |
コニカミノルタエムジー株式会社 |
抗腫瘍リポソーム製剤およびその製造方法
|
|
JP2006069929A
(ja)
*
|
2004-08-31 |
2006-03-16 |
Konica Minolta Medical & Graphic Inc |
真菌症治療製剤およびその製造方法
|
|
AU2005281352B2
(en)
|
2004-09-09 |
2011-01-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal compositions of glucocorticoid and glucocorticoid derivatives
|
|
US7527588B2
(en)
*
|
2004-09-15 |
2009-05-05 |
Ethicon, Inc. |
System and method for surgical implant placement
|
|
KR20070089693A
(ko)
*
|
2004-11-08 |
2007-08-31 |
트랜세이브, 인코포레이티드 |
지질-기재 플래티넘 화합물 제형을 복막내 투여하여 암을치료하는 방법
|
|
US7481314B2
(en)
*
|
2005-02-02 |
2009-01-27 |
Ethicon, Inc. |
Packaging assembly for surgical mesh implants
|
|
JP2006248978A
(ja)
*
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
US20060283742A1
(en)
*
|
2005-06-16 |
2006-12-21 |
Canel Lightning Co. Ltd. |
Multi-lamp display packaging for lamps with collapsible lampshades
|
|
CN1913508B
(zh)
*
|
2005-08-08 |
2010-05-05 |
华为技术有限公司 |
基于正交频分复用的信号调制方法及其调制装置
|
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
|
AU2006294644A1
(en)
*
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
WO2007056236A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
|
|
WO2007056263A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
|
|
US20070190182A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US9107824B2
(en)
*
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US20070122350A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Transave, Inc. |
Safe and effective methods of administering therapeutic agents
|
|
ES2798263T3
(es)
|
2005-12-08 |
2020-12-10 |
Insmed Inc |
Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
|
|
CA2841386A1
(en)
|
2005-12-30 |
2007-07-12 |
Zensun (Shanghai) Science & Technology Limited |
Extended release of neuregulin for improved cardiac function
|
|
EP1980243A1
(de)
*
|
2006-02-03 |
2008-10-15 |
Takeda Pharmaceutical Company Limited |
Liposom-präparat
|
|
JP5364381B2
(ja)
*
|
2006-12-08 |
2013-12-11 |
片山化学工業株式会社 |
アンミン白金錯体を高濃度で内包するリポソームおよびその製造方法
|
|
US8278415B2
(en)
|
2006-12-21 |
2012-10-02 |
Centocor, Inc. |
Dimeric high affinity EGFR constructs and uses thereof
|
|
WO2008079982A2
(en)
|
2006-12-21 |
2008-07-03 |
Centocor, Inc. |
Liposome composition for targeting egfr receptor
|
|
WO2008079973A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Centocor, Inc. |
Egfr binding peptides and uses thereof
|
|
WO2008137717A1
(en)
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
|
CA2695374A1
(en)
*
|
2007-08-15 |
2009-02-19 |
Amunix, Inc. |
Compositions and methods for modifying properties of biologically active polypeptides
|
|
WO2009097011A1
(en)
|
2007-08-17 |
2009-08-06 |
Celator Pharmaceuticals, Inc. |
Improved platinum drug formulations
|
|
CN101878229A
(zh)
|
2007-09-28 |
2010-11-03 |
巴塞尔大学医院 |
用于治疗癌症的免疫脂质体
|
|
US20090130017A1
(en)
*
|
2007-11-19 |
2009-05-21 |
Searete Llc |
Targeted short-lived drug delivery
|
|
TWI468188B
(zh)
*
|
2008-01-30 |
2015-01-11 |
Univ Tokushima |
Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
|
|
JP5542804B2
(ja)
*
|
2008-05-23 |
2014-07-09 |
ザ ユニヴァーシティ オブ ブリティッシュ コロンビア |
リポソームナノ粒子中で使用するための修飾薬物
|
|
US20100035853A1
(en)
*
|
2008-08-07 |
2010-02-11 |
Hyogo College Of Medicine |
Method for preventing or treating cisplatin-induced nephrotoxicity
|
|
US9322831B2
(en)
*
|
2008-09-23 |
2016-04-26 |
The Johns Hopkins University |
DDX3 as a biomarker for cancer and methods related thereto
|
|
US8449573B2
(en)
|
2008-12-05 |
2013-05-28 |
Boston Scientific Scimed, Inc. |
Insertion device and method for delivery of a mesh carrier
|
|
DK3178835T3
(da)
|
2009-02-03 |
2019-06-24 |
Amunix Pharmaceuticals Inc |
Forlængede rekombinante polypeptider og sammensætninger omfattende samme
|
|
EP2228059A1
(de)
|
2009-03-12 |
2010-09-15 |
Universitätsspital Basel |
Chemotherapeutische Zusammensetzung für die Krebsbehandlung
|
|
US20120148661A1
(en)
*
|
2009-04-15 |
2012-06-14 |
Poniard Pharmaceuticals, Inc. |
High bioavailability oral picoplatin anti-cancer therapy
|
|
US8968334B2
(en)
|
2009-04-17 |
2015-03-03 |
Boston Scientific Scimed, Inc. |
Apparatus for delivering and anchoring implantable medical devices
|
|
WO2010144508A1
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
PE20121539A1
(es)
|
2009-06-08 |
2012-12-06 |
Amunix Operating Inc |
Polipeptidos de la hormona de crecimiento y metodos de preparacion
|
|
WO2010143193A1
(en)
|
2009-06-11 |
2010-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Targeted liposomes comprising n-containing bisphosphonates and uses thereof
|
|
CA2771999A1
(en)
|
2009-08-24 |
2011-03-10 |
Amunix Operating Inc. |
Coagulation factor vii compositions and methods of making and using same
|
|
DK177529B1
(en)
*
|
2009-10-23 |
2013-09-08 |
Bio Bedst Aps |
Liposomes with improved storage stability
|
|
BR112012009801A8
(pt)
|
2009-10-30 |
2016-08-30 |
Cns Therapeutics Inc |
Polipeptídeo neurturina e variante de neurturina
|
|
US9301750B2
(en)
*
|
2009-11-03 |
2016-04-05 |
Boston Scientific Scimed, Inc. |
Device and method for delivery of mesh-based devices
|
|
WO2011092708A2
(en)
|
2010-02-01 |
2011-08-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Liposomes comprising amphipathic drugs and method for their preparation
|
|
US9518114B2
(en)
|
2010-11-12 |
2016-12-13 |
Purdue Research Foundation |
Treating bladder tumor cells using fibronectin attachment protein as a target
|
|
EP2508176A1
(de)
|
2011-04-08 |
2012-10-10 |
Lipotarg Gmbh |
Neues Kombinatonsbehandlung für Krebs
|
|
LT2731591T
(lt)
|
2011-07-13 |
2020-12-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Liposomos, kuriose kartu inkapsuliuotas bisfosfonatas ir amfipatinis agentas
|
|
WO2013114377A1
(en)
|
2012-02-02 |
2013-08-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd |
Stable liposomes for drug delivery
|
|
CN111548418A
(zh)
|
2012-02-15 |
2020-08-18 |
比奥贝拉蒂治疗公司 |
因子viii组合物及其制备和使用方法
|
|
WO2013123457A1
(en)
|
2012-02-15 |
2013-08-22 |
Biogen Idec Ma Inc. |
Recombinant factor viii proteins
|
|
PL2852391T3
(pl)
|
2012-05-21 |
2022-04-11 |
Insmed Incorporated |
Układy do leczenia infekcji płuc
|
|
US9156897B2
(en)
|
2012-06-08 |
2015-10-13 |
Alkermes, Inc. |
Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
|
|
WO2014015027A1
(en)
|
2012-07-18 |
2014-01-23 |
Onyx Therapeutics, Inc. |
Liposomal compositions of epoxyketone-based proteasome inhibitors
|
|
MA37931A1
(fr)
*
|
2012-08-13 |
2016-07-29 |
Teni Boulikas |
Procédés améliorés permettant de traiter un cancer avec une toxicité rénale réduite
|
|
EP2892524B1
(de)
|
2012-09-04 |
2020-11-25 |
Eleison Pharmaceuticals, LLC |
Prävention eines lungenkarzinomrezidivs mit lipidkomplexiertem cisplatin
|
|
US20150246137A1
(en)
*
|
2012-09-27 |
2015-09-03 |
The University Of North Carolina At Chapel Hill |
Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof
|
|
CA2891487A1
(en)
|
2012-11-29 |
2014-06-05 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
|
US9556214B2
(en)
*
|
2012-12-19 |
2017-01-31 |
Placon Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of cancers
|
|
CA2903234C
(en)
*
|
2013-03-13 |
2018-08-28 |
Mallinckrodt Llc |
Liposome oxaliplatin compositions for cancer therapy
|
|
CA2903254C
(en)
|
2013-03-13 |
2019-04-09 |
Mallinckrodt Llc |
Liposomal cisplatin compositions for cancer therapy
|
|
US10548953B2
(en)
|
2013-08-14 |
2020-02-04 |
Bioverativ Therapeutics Inc. |
Factor VIII-XTEN fusions and uses thereof
|
|
US9987375B2
(en)
*
|
2013-09-23 |
2018-06-05 |
Amirhossein Sahebkar |
Method and composition for treatment of dyslipidemia and other diseases
|
|
EA201691111A1
(ru)
|
2014-01-10 |
2017-01-30 |
Байоджен Ма Инк. |
Химерные белки фактора viii и их применение
|
|
CN107124869B
(zh)
|
2014-03-25 |
2022-04-01 |
美国政府陆军部 |
包含含有单磷酰脂质a（mpla）的脂质体组合物和皂苷的无毒佐剂制剂
|
|
MX384843B
(es)
|
2014-05-15 |
2025-03-14 |
Insmed Inc |
Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas.
|
|
AU2016233143B2
(en)
|
2015-03-17 |
2021-03-25 |
Alberto Gabizon |
Methods for the treatment of bladder cancer
|
|
UA126016C2
(uk)
|
2015-08-03 |
2022-08-03 |
Біовератів Терапеутікс Інк. |
Злитий білок фактора іх
|
|
IL286493B
(en)
|
2015-11-06 |
2022-07-01 |
Memorial Sloan Kettering Cancer Center |
Triterpene saponin analogues, methods of producing same, compositions comprising same and uses thereof
|
|
FR3051674B1
(fr)
*
|
2016-05-31 |
2019-11-08 |
Universite De Bourgogne |
Lipoproteines chargees en complexes de platine pour le traitement du cancer
|
|
CN109996809A
(zh)
|
2016-11-14 |
2019-07-09 |
诺华股份有限公司 |
与促融合蛋白minion相关的组合物、方法和治疗用途
|
|
KR20190090827A
(ko)
|
2016-12-02 |
2019-08-02 |
바이오버라티브 테라퓨틱스 인크. |
키메라 응고 인자를 사용해 혈우병성 관절증을 치료하는 방법
|
|
CN110582282A
(zh)
|
2017-04-25 |
2019-12-17 |
佐剂技术公司 |
三萜皂苷类似物
|
|
JP2020536946A
(ja)
|
2017-10-16 |
2020-12-17 |
アジュバンス・テクノロジーズ・インコーポレーテッド |
トリテルペンサポニン類似物
|
|
EP3706801B1
(de)
*
|
2017-11-08 |
2026-01-14 |
L.E.A.F Holdings Group LLC |
Platinkomplexe und verwendungen davon
|
|
EP3773505B1
(de)
|
2018-03-30 |
2026-04-29 |
Insmed Incorporated |
Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
|
|
EP3787602A4
(de)
|
2018-05-02 |
2022-03-23 |
Insmed Incorporated |
Verfahren zur herstellung von liposomalen arzneimittelformulierungen
|
|
KR102914074B1
(ko)
|
2018-05-18 |
2026-01-16 |
바이오버라티브 테라퓨틱스 인크. |
A형 혈우병의 치료 방법
|
|
AU2020379738A1
(en)
|
2019-11-05 |
2022-04-14 |
Adjuvance Technologies, Inc. |
Varicella zoster
|
|
WO2021183588A1
(en)
*
|
2020-03-10 |
2021-09-16 |
Chung Yuan Christian University |
Liposome composition and preparation method thereof
|
|
PH12022553407A1
(en)
|
2020-06-25 |
2024-04-22 |
Amunix Pharmaceuticals Inc |
Her-2 targeted bispecific compositions and methods for making and using the same
|
|
WO2022204267A1
(en)
|
2021-03-24 |
2022-09-29 |
Alkermes, Inc. |
Upar antibodies and fusion proteins with the same
|
|
CN114163481B
(zh)
*
|
2021-12-06 |
2023-06-23 |
郑州大学 |
一种含铂类药物纳米囊泡及其制备方法与应用
|
|
AU2023235562B2
(en)
|
2022-03-14 |
2026-07-30 |
Pfizer Inc. |
Methods for producing an adjuvant
|
|
CN120513083A
(zh)
|
2022-12-01 |
2025-08-19 |
辉瑞大药厂 |
肺炎链球菌缀合物疫苗制剂
|
|
CN116687860A
(zh)
*
|
2023-05-31 |
2023-09-05 |
广州鹏兴医药科技有限公司 |
顺铂靶向脂质体及其制备方法和应用
|
|
TWI909678B
(zh)
|
2023-09-13 |
2025-12-21 |
美商輝瑞股份有限公司 |
產製佐劑之方法
|
|
TW202602467A
(zh)
|
2024-03-11 |
2026-01-16 |
美商輝瑞股份有限公司 |
包含經共軛之大腸桿菌糖的免疫原性組成物及其用途
|
|
WO2026088120A1
(en)
|
2024-10-24 |
2026-04-30 |
Pfizer Inc. |
Lipidated tlr7/8 modulators as adjuvants and uses thereof
|
|
US20260166136A1
(en)
|
2024-12-18 |
2026-06-18 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|